Multiplex Biomarker Imaging Market 2028 By Component Type, Imaging Technique Assay, Application and Geography | The Insight Partners

report image

Multiplex Biomarker Imaging Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component Type (Instruments, Softwares, Services); Imaging Technique (Immunohistochemistry (IHC) Assay, Fluorescent In Situ Hybridization (FISH) Assay, Tissue Microarray (TMA) Assay); Application (Research, Clinical Diagnostics, Translational Laboratories, Biopharmaceutical Companies, Academic Institutes) and Geography

Report Code: TIPRE00006878 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

MARKET OVERVIEW

Multiplex biomarker imaging is a technique for identifying and analysing diseases in the body. Biomarkers are used in clinical investigations to determine disease progression and to aid in the study of biological systems by allowing the expression of various biomarkers to be checked. The factors driving the multiplex biomarker imaging market are, rising prevalence of chronic diseases and increasing demand for multiplex biomarker imaging.

MARKET SCOPE

The "Global Multiplex Biomarker Imaging Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the multiplex biomarker imaging market with detailed market segmentation by component type, imaging technique and application. The report provides key statistics on the market status of the leading multiplex biomarker imaging market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on component type the market is segmented as, instruments, software, services.
  •   Based on imaging technique the market is segmented as, immunohistochemistry (IHC) assay, fluorescent in situ hybridization (FISH) assay, and tissue microarray (TMA) assay.
  •   Based on application the market is segmented as, research, clinical diagnostics, translational laboratories, biopharmaceutical companies, and academic institutes.

MARKET DYNAMICS
Drivers:

  •   Rising utilization of multiplex biomarker in oncology and immunology and research, increasing prevalence of cancer and other chronic disorders.
  •   Increasing demand for multiplex biomarker imaging is also expected to spur the market growth.
  •   Rising expenditures on healthcare sector is also expected to fuel the market growth.

Restraints:

  •   However, presence of stringent regulatory framework along with complexity of the process are likely to restrain market growth during the forecast period.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The multiplex biomarker imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the multiplex biomarker imaging market in these regions.

IMPACT OF COVID-19 ON MULTIPLEX BIOMARKER IMAGING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the multiplex biomarker imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from multiplex biomarker imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for multiplex biomarker imaging in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the multiplex biomarker imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Bio-Rad Laboratories, Inc
  •   Luminex Corporation
  •   Merck KGaA
  •   BioTek Instruments
  •   Akoya Biosciences, Inc
  •   Miltenyi Biotec
  •   R and D Systems, Inc
  •   Leica Biosystems Nussloch GmbH
  •   PerkinElmer
  •   Thermo Fisher Scientific, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

- Bio-Rad Laboratories, Inc
- Luminex Corporation
- Merck KGaA
- BioTek Instruments
- Akoya Biosciences, Inc
- Miltenyi Biotec
- R and D Systems, Inc
- Leica Biosystems Nussloch GmbH
- PerkinElmer
- Thermo Fisher Scientific, Inc
- OLYMPUS CORPORATION
- Quanterix
- General Electric
TIPRE00006878
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount